Archives

  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • (S)-(+)-Dimethindene maleate: M2 Antagonist for Research Wor

    2026-04-13

    (S)-(+)-Dimethindene maleate: Technical Guide for M2 Muscarinic Antagonist Use

    What This Product Solves

    (S)-(+)-Dimethindene maleate is a small molecule antagonist with established selectivity for the muscarinic acetylcholine receptor M2 subtype, while exhibiting reduced affinity for M1, M3, and M4 subtypes. Additionally, it antagonizes the histamine H1 receptor. This pharmacological profile enables targeted investigation of M2-dependent signaling within autonomic regulation research, cardiovascular physiology studies, and respiratory system function research. By offering dual antagonism, researchers can dissect overlapping receptor contributions in complex cell or tissue models, particularly where muscarinic and histaminergic pathways intersect. The high purity (98.00%) and water solubility facilitate reproducible preparation for in vitro assays, with clear handling and storage guidelines minimizing batch-to-batch variability. This reagent is intended solely for scientific research and is not validated for medical or diagnostic applications.

    For further context on workflow integration and pathway interrogation, see the article "(S)-(+)-Dimethindene maleate: Precision Tool for M2 Receptor Studies", which offers guidance on troubleshooting and integration in high-fidelity pharmacological research. Additionally, the article "(S)-(+)-Dimethindene maleate: Reproducibility in Receptor Pathway Research" provides scenario-driven strategies for maintaining reproducibility in complex biomedical models.

    Protocol Parameters

    • Solubility preparation | ≥20.45 mg/mL in water | All in vitro pharmacological assays | Ensures full dissolution and compatibility with aqueous assay systems | product_spec [product_url]
    • Storage condition | Desiccated, room temperature (solid) | Routine lab storage | Preserves compound stability and prevents hydrolysis or degradation | product_spec [product_url]
    • Solution handling | Prepare fresh; avoid long-term storage | Assays requiring solution dosing | Minimizes risk of compound decomposition and ensures reproducibility | product_spec [product_url]
    • Working concentration | User-defined, titrate as per assay sensitivity | Cellular/biochemical receptor binding or signaling studies | Start with micromolar range and optimize based on observed receptor response | workflow_recommendation
    • Purity | 98.00% | All experimental setups | Limits confounding effects from contaminants in pathway analysis | product_spec [product_url]

    Workflow Setup and QC Checklist

    1. Confirm product identity, lot number, and integrity upon receipt. Inspect for physical consistency and dryness.
    2. For stock solution, weigh the compound using an analytical balance and dissolve in water to achieve a concentration at or above 20.45 mg/mL. Vortex thoroughly until fully dissolved. If necessary, use sonication for stubborn particulates.
    3. Filter-sterilize solutions for sterile applications, using 0.22 µm PVDF or PTFE filters. Prepare aliquots to avoid repeated freeze-thaw or room temperature cycling.
    4. Do not store working solutions long-term; prepare fresh immediately before use to preserve compound activity.
    5. Validate receptor antagonism in pilot assays using known M2 or H1 function readouts (e.g., cAMP modulation, calcium flux, or downstream gene expression changes). Include negative and positive controls for specificity assessment.
    6. Document batch, preparation date, and storage conditions for all working solutions to support experimental reproducibility.

    Common Failure Modes and Fixes

    • Incomplete dissolution: If the compound does not dissolve at the recommended concentration, verify water purity, increase mixing time, or gently warm to 37°C. Avoid use of organic solvents unless assay compatibility is confirmed.
    • Loss of activity in solution: If pharmacological activity is reduced, discard old solutions and prepare fresh from solid stock. Avoid storing solutions at room temperature for extended periods.
    • Non-specific effects in receptor assays: Confirm selectivity using orthogonal controls (e.g., M1/M3/M4 cell lines or antagonists). Titrate compound concentration to minimize off-target effects.
    • Precipitation in cell culture media: Pre-dilute in water, then add gradually to media with continuous mixing. If precipitation persists, reduce stock concentration or test in alternative buffer systems.

    Scope and Limitations

    (S)-(+)-Dimethindene maleate is well-suited for in vitro and ex vivo receptor pharmacology, including studies of muscarinic acetylcholine receptor signaling pathways, autonomic regulation, and cardiovascular or respiratory system function. It is not validated for in vivo administration, diagnostic use, or clinical application. Users should not extrapolate findings to human or animal models without additional validation. The compound’s reduced affinity for M1, M3, and M4 subtypes makes it a preferred tool for selective M2 receptor interrogation, but off-target effects should be systematically controlled for. Always consult the (S)-(+)-Dimethindene maleate product page for the latest handling and safety instructions.

    Conclusion

    (S)-(+)-Dimethindene maleate (SKU B6734) offers a robust, selective approach to dissecting muscarinic M2 and histamine H1 receptor contributions in cell-based and biochemical assays. Adhering to solubility, storage, and workflow parameters is critical for preserving reagent fidelity and reproducibility. For further guidance on integrating this compound into M2-selective pharmacological workflows, APExBIO provides detailed product specifications and technical support to facilitate reliable, high-quality research outcomes.